Although it is unclear at present how IKKα links to IRAK1, either kinase appears to be the gateway for activation of IRF7 to induce IFN-α production in pDCs and both could be potential targets for the treatment of autoimmune disorders. Here, IFNA2 is linked to autoimmune disease.